PTC Therapeutics
PTCT
NZ$79.73
Share price
-2.22%
Change (1 day)
54.07%
Change (1 year)
Categories
PTC Therapeutics (PTCT) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : NZ$4.72 Billion
According to PTC Therapeutics 's latest financial reports the company's total liabilities are NZ$4.72 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
PTC Therapeutics - Total liabilities on balance sheet (from 2012 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | NZ$4.97 B | 15.8% |
| 2023-12-31 | NZ$4.29 B | 32.75% |
| 2022-12-31 | NZ$3.23 B | 14.03% |
| 2021-12-31 | NZ$2.83 B | 18.51% |
| 2020-12-31 | NZ$2.39 B | 56.52% |
| 2019-12-31 | NZ$1.52 B | 33.42% |
| 2018-12-31 | NZ$1.14 B | 245.92% |
| 2017-12-31 | NZ$0.33 B | 53.19% |
| 2016-12-31 | NZ$0.21 B | 6.24% |
| 2015-12-31 | NZ$0.20 B | 358.81% |
| 2014-12-31 | NZ$44.35 M | 137.28% |
| 2013-12-31 | NZ$18.69 M | -52.34% |
| 2012-12-31 | NZ$39.22 M | -89.17% |
| 2011-12-31 | NZ$0.36 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Vertex Pharmaceuticals VRTX | NZ$10.60 B | 124.70% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | NZ$3.85 B | -18.25% | 🇺🇸 USA |
 Fate Therapeutics
FATE | NZ$0.18 B | -96.12% | 🇺🇸 USA |
 Avidity Biosciences RNA | NZ$0.21 B | -95.41% | 🇺🇸 USA |
 Xencor XNCR | NZ$0.44 B | -90.68% | 🇺🇸 USA |
 Novartis NVS | NZ$102.18 B | 2,064.23% | 🇨🇭 Switzerland |